Tuesday, September 8, 2026
ExploreSearch
Via News
MarketFX

USD/CNH Bullish Momentum With A 1% Rise In The Last 10 Sessions

ViaNews Editorial Team

October 13, 2024

USD/CNH Bullish Momentum With A 1% Rise In The Last 10 Sessions

(VIANEWS) - USD/CNH (USDCNH) has been up by 1.38% for the last 10 sessions. At 14:13 EST on Sunday, 13 October, USD/CNH (USDCNH) is $7.07.

USD/CNH's yearly highs and lows, it's 0% down from its 52-week low and 0.021% down from its 52-week high.

News about

  • Eur/usd struggles to gain ground below 1.0950 ahead of German inflation data. According to FXStreet on Friday, 11 October, "The EUR/USD pair remains on the defensive around 1.0935 during the early European session on Friday. "

More news about USD/CNH (USDCNH).

Categories

MarketFX

Tags

ForexForeign Exchange MarketCurrenciesUSDCNHUSD/CNHFOREX Price UpPrice UpForex Now
ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
AI Investment Boom Meets Market Skepticism: Palantir's Contract Win vs. Stock Slide Amid Record Private AI Funding
Palantir secured the Army's high-profile TITAN AI-sensing contract and added a new executive, yet its stock fell 6% the same day — a sign that even marquee government AI wins no longer guarantee investor confidence. This tension plays out against a backdrop of surging private capital flooding into AI and AI-adjacent companies (Stability AI, Socure, Generalist AI, Emerald AI, and others), showing a bifurcated market: venture funding for AI remains red-hot while public-market sentiment toward AI-defense/enterprise plays is growing more cautious.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
General Motors Company
Both facts reference General Motors' cash position at the identical point in time (2025-12-31), both measuring FY 2025 period-end. Fact A reports $20.945 billion while Fact B reports $21.7 billion—a $755 million discrepancy (3.6% difference). Since they share the same entity, attribute, date, and fiscal period with conflicting values, this is a genuine contradiction, not a change over time. The difference is material enough to suggest either: different source data, different cash classifications (e.g., one includes equivalents/restricted cash), preliminary vs. final figures, or a data quality issue.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,981
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,981 facts checked against source5,278 source documents archived
Query this data → isubstrate.com